CD Capital
Funding rounds backed by CD Capital.
- Funding disclosed in full
- $21M
- Median round
- $21M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| CORE Biomedicine Developing the next generation of precision medicines by going beyond genomics. | $21MSeries A | BiotechUnited States |